Myomo Inc. (MYO)
| Bid | 4.69 |
| Market Cap | 171.08M |
| Revenue (ttm) | 32.55M |
| Net Income (ttm) | -6.18M |
| EPS (ttm) | -0.16 |
| PE Ratio (ttm) | -29.72 |
| Forward PE | 156.83 |
| Analyst | Strong Buy |
| Ask | 5.01 |
| Volume | 209,730 |
| Avg. Volume (20D) | 415,604 |
| Open | 4.80 |
| Previous Close | 4.70 |
| Day's Range | 4.64 - 4.83 |
| 52-Week Range | 2.76 - 7.17 |
| Beta | 1.54 |
About MYO
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents wit...
Analyst Forecast
According to 4 analyst ratings, the average rating for MYO stock is "Strong Buy." The 12-month stock price forecast is $10.25, which is an increase of 115.56% from the latest price.
Stock ForecastsNext Earnings Release
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago · businesswire.com
Myomo to Present at the 24th Annual Needham Virtual Healthcare ConferenceBURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
1 month ago · businesswire.com
Myomo to Report Fourth Quarter 2024 Financial Results on March 10BURLINGTON, Mass.--(BUSINESS WIRE)--Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurol...
